Enhanced Nanocellulose Implants for Bile Duct Repair

Publication ID: 24-11857405_0001_PTD
Published: October 28, 2025
Category:Direct Improvements & Enhancements

Legal Citation

pr1or.art Inc., “Enhanced Nanocellulose Implants for Bile Duct Repair,” Published Technical Disclosure No. 24-11857405_0001_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857405_0001_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,405.

Summary of the Inventive Concept

The present inventive concept discloses novel enhancements to nanocellulose implants for bile duct repair, addressing the limitations of existing implants by providing improved structural integrity, biocompatibility, and tissue regeneration capabilities.

Background and Problem Solved

The original patent for medical implants based on nanocellulose highlighted the need for improved bile duct reconstruction in hepato-biliary surgery. However, the existing implants may still suffer from collapse, limited biocompatibility, and inadequate tissue regeneration. The new inventive concept addresses these limitations by introducing reinforced inner layers, hydrophilic coatings, spiral-shaped reinforcement structures, bioactive substances, and porous outer layers.

Detailed Description of the Inventive Concept

The inventive concept encompasses four primary enhancements to nanocellulose implants: 1) a reinforced inner layer formed by injecting biocompatible materials to prevent collapse; 2) a hydrophilic coating applied to the inner surface to enhance biocompatibility; 3) a spiral-shaped reinforcement structure created by helically wrapping thin films of biocompatible material around the tube; and 4) a porous outer layer incorporating biodegradable microparticles to promote tissue regeneration. These enhancements can be combined in various ways to create implants with tailored properties for specific bile duct repair applications.

Novelty and Inventive Step

The new claims introduce novel and non-obvious enhancements to nanocellulose implants, providing a significant improvement over the original patent. The reinforced inner layer, hydrophilic coating, spiral-shaped reinforcement structure, and porous outer layer offer distinct advantages in terms of structural integrity, biocompatibility, and tissue regeneration capabilities.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept may include varying the materials used for the reinforced inner layer, hydrophilic coating, and spiral-shaped reinforcement structure. Additionally, the porous outer layer could be modified to incorporate different types of biodegradable microparticles or bioactive substances. These variations could lead to implants with tailored properties for specific applications or patient populations.

Potential Commercial Applications and Market

The enhanced nanocellulose implants have significant commercial potential in the medical device industry, particularly in the field of hepato-biliary surgery. The targeted market includes hospitals, surgical centers, and medical research institutions focused on bile duct repair and reconstruction.

CPC Classifications

SectionClassGroup
A A61 A61F2/04
A A61 A61L31/005
A A61 A61L31/10
A A61 A61L31/146
A A61 A61F2002/041
A A61 A61L2400/12
A A61 A61L2420/08
C C08 C08L1/02

Field of Art

Medical device engineering, specifically biomaterials for surgical implants, with expertise in nanocellulose-based medical tubes and tissue regeneration techniques

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or materials scientist with advanced degree, experience in biomaterial design, knowledge of microbial cellulose fabrication, and understanding of surgical implant modification techniques

Obviousness Rationale

A PHOSITA would recognize that the proposed enhancements to the nanocellulose implant represent predictable variations using standard biomedical engineering techniques. The source patent establishes a foundational nanocellulose tube design, and the PTD's modifications represent logical extensions using known biocompatible materials and structural reinforcement strategies commonly employed in medical implant development.

Obvious Combinations & Variations

Source Patent Element
Microbial cellulose tube with concentric layers
PTD Variation
Reinforced inner layer by injecting biocompatible materials
Obviousness Reasoning
Preventing tube collapse is a predictable design improvement using known material injection techniques, representing a standard engineering solution to structural stability
Source Patent Element
Tubular medical implant for bile duct reconstruction
PTD Variation
Hydrophilic coating on inner surface to enhance biocompatibility
Obviousness Reasoning
Surface modification to improve tissue interaction is a well-established technique in biomaterial design, representing a finite and predictable solution to implant integration
Source Patent Element
Microbial cellulose tube with potential for dimensional modification
PTD Variation
Spiral-shaped reinforcement structure using helically wrapped biocompatible films
Obviousness Reasoning
Structural reinforcement through helical wrapping is a known engineering technique for enhancing mechanical properties of tubular medical devices
Source Patent Element
Nanocellulose tube for medical implantation
PTD Variation
Porous outer layer incorporating biodegradable microparticles
Obviousness Reasoning
Incorporating biodegradable particles to promote tissue regeneration represents a standard approach in biomaterial design for enhancing implant integration
35 U.S.C. § 103 Summary: Based on US Patent 11857405 and the corresponding Published Technical Disclosure, a person having ordinary skill in the art would find the proposed nanocellulose implant variations obvious and lacking inventive step. The modifications represent predictable engineering solutions using known biomedical techniques, thereby rendering subsequent claims of novelty invalid under 35 U.S.C. Section 103.

Original Patent Information

Patent NumberUS 11,857,405
TitleMedical implant based on nanocellulose
Assignee(s)UNIVERSITÄTSKLINIKUM JENA